Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Amer Jaber
COO | Chief Operating Officer | - | 18-12-31 |
Daniel Smith
CTO | Chief Tech/Sci/R&D Officer | - | 16-04-10 |
Nicola Lamacchia
BRD | Director/Board Member | - | 17-02-28 |
Nunzio Antonelli
BRD | Director/Board Member | - | 15-11-09 |
Valerie Benhamou
SEC | Corporate Secretary | - | 19-05-15 |
Jérôme Tilly
HRO | Human Resources Officer | - | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nunzio Antonelli
BRD | Director/Board Member | - | 15-11-09 |
Nicola Lamacchia
BRD | Director/Board Member | - | 17-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,728,000 | 0 | 0 | - |
Company contact information
Stallergenes Greer Ltd.
Tower Bridge House St Katharine's Way
E1W 1DD, London
+
http://www.stallergenesgreer.comGroup companies
Name | Category and Sector |
---|---|
Stallergenes SAS
|
Sector
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+5.48% | 71.19B | |
+12.55% | 9.3B | |
-13.75% | 5.01B | |
+42.38% | 4.47B | |
+4.51% | 3.96B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B | |
+6.53% | 1.69B |
- Stock Market
- Equities
- STAGR Stock
- Company Stallergenes Greer